BioDuro-Sundia Announces New CEO | Company

SAN DIEGO & SHANGHAI–(Business WIRE)–Feb 8, 2021–

BioDuro-Sundia, a top drug discovery and enhancement services business backed by Introduction International, announced nowadays the appointment of Haijun Dong, PhD, MBA as Chief Govt Officer.

Dong will choose over from Cyrus K. Mirsaidi, who most just lately led the organization through its 2020 integration, setting up BioDuro-Sundia as the No. 3 CRDMO in the marketplace, with a lot more than 2,000 personnel and operations in 7 towns throughout China and the US. The govt staff, now led by Dong, will carry on to be co-found in each China and the US, delivering harmony for the world-wide company units that support all factors of drug discovery, advancement, and manufacturing—both drug material and drug products.

“Our leaders and investors have executed a roadmap of productive development for BioDuro-Sundia that has now made a normal issue for the corporation to transition management. We are really privileged to have anyone of Haijun’s pedigree and vision lead our company into the following period of that growth—both natural and inorganic,” mentioned David Preston, Chairman of the Board, BioDuro-Sundia. “Haijun has deep China and US working experience in drug discovery, improvement, and expert services, which include community markets. He has unbelievable dedication to producing workers and customers alike. These factors make him a pure healthy for a enterprise like ours, that is so extraordinarily current market and people focused.”

BioDuro-Sundia’s staff and services have seen quick expansion in the past yr, with two new web sites in China—an R&D foundation in Wuxi Metropolis and a producing heart in Bengbu—that include capability for additional than 1,000 new staff.

“I am incredibly fired up to sign up for BioDuro-Sundia, a CRDMO that has grown yr right after calendar year as a key player in both equally functionality and scale for integrated drug discovery, development and production expert services,” claimed Haijun. “The progress probable in China and the US is enormous. Our the latest expansions in Wuxi Metropolis and Bengbu will fuel that development, but we count on even far more on the horizon. Key to it all is operational excellence and determination to quality—which, of study course, are delivered by way of a crew of focused and industry-most effective personnel. These are values that will hardly ever adjust.”

Dong has been a main Normal Supervisor & CEO in China for 10+ decades, with expertise in huge multinational businesses, together with Roche and Eli Lilly. He has a strong qualifications and formal training in both of those complex field and business management, a Ph.D. in Chemistry from the College of Washington, and an MBA from the China Europe Worldwide Small business School. Dong has a tested keep track of history of excellence in building and handling organizations and organization units, all of which have sent market place-main success. He is also a identified KOL in drug discovery, progress, and products and services.

BioDuro-Sundia’s outgoing CEO, Cyrus K. Mirsaidi, joined the enterprise as BioDuro’s CEO in 2015, and has considering the fact that led the organization progress from: 500 workers to 2,000+ workforce and from 3 web pages to 10 world wide sites—including acquisitions of Formex in 2015, Molecular Reaction in 2018, and the merger with Sundia in 2020. Mirsaidi will proceed to serve as Advisor to BioDuro-Sundia’s Board of Administrators and leadership workforce.

“On behalf of our shareholders and the Board, we would like a large thank you to Cyrus, who’s vision has now established BioDuro-Sundia into the 3 rd biggest CRDMO with key China and US operations,” explained Preston. “BioDuro-Sundia was created under his leadership more than the previous 5 years. We are seeking ahead to his continued guidance that will support the enterprise and our new management to accomplish even more achievements in the next 5 many years, and further than.”

About BioDuro-Sundia

BioDuro-Sundia, an Arrival Intercontinental portfolio corporation, is a primary agreement analysis, improvement and manufacturing group (CRDMO) that presents biopharmaceutical associates with absolutely integrated services to help drug discovery, development and production for both of those drug substance and drug item. The business is the industry’s third most significant, with significant functions in China and the US—featuring far more than 2,000 staff members and 10 worldwide sites.

Core know-how includes modest and large molecule discovery, development and scale up, help for IND submission, and special technologies platforms these kinds of as bioavailability enhancement of insoluble compounds. The business has study websites, as perfectly as GMP manufacturing facilities in each China and the US. The a single-end-store operation allows biopharma partners throughout the world to considerably accelerate discovery and de-possibility enhancement to produce greater value outcomes.

BioDuro-Sundia financial commitment is led by Advent International, with backing from Bridgewest Organization Team.

For additional facts, take a look at:

About Arrival Worldwide

Started in 1984, Advent Intercontinental is 1 of the biggest and most expert world wide private fairness buyers. The firm has invested in in excess of 350 non-public fairness transactions in 41 countries, and as of June 30, 2020, experienced $58.4 billion in belongings less than administration. With 15 places of work in 12 nations around the world, Arrival has founded a globally integrated staff of above 200 financial commitment gurus throughout North The usa, Europe, Latin The us and Asia. The company focuses on investments in five core sectors, including business enterprise and monetary services well being treatment industrial retail, customer and leisure and know-how. Just after 35 decades focused to international investing, Advent remains fully commited to partnering with management teams to produce sustained revenue and earnings advancement for its portfolio businesses.

For extra info, check out:

About Bridgewest Business Team

Started in 1999, The Bridgewest Enterprise Group is a intently held investment company that seeks to build lengthy time period benefit by means of application of superior field expertise, operational abilities and substantial money means to eye-catching financial commitment opportunities. The Group buildings its world wide investments throughout four practical spots including non-public fairness, genuine estate, capital marketplaces and money companies. The Group’s private fairness investments are largely in biotech, wi-fi communications, infrastructure for IoT, and semiconductor. Bridgewest is based in San Diego, CA and has investments across the United states of america, Europe, Asia and Australasia.

Check out source edition on

Get hold of: Sam Bhattacharya, Marketing Supervisor

[email protected]

[email protected]


Marketplace Search phrase: Health General Health and fitness Investigation PHARMACEUTICAL SCIENCE BIOTECHNOLOGY

Source: BioDuro-Sundia

Copyright Enterprise Wire 2021.

PUB: 02/08/2021 09:00 PM/DISC: 02/08/2021 09:00 PM